GRK5
Top inhibitors
| Drug | Inhibition % | Gini |
|---|---|---|
| Lorlatinib | 20.1 | 0.69 |
| Repotrectinib | 17.0 | 0.61 |
| Midostaurin | 16.2 | 0.50 |
| Nintedanib | 15.1 | 0.61 |
| Darovasertib | 13.3 | 0.72 |
| Pemigatinib | 10.6 | 0.72 |
| Ceritinib | 8.2 | 0.62 |
| Crizotinib | 8.2 | 0.58 |
| Capivasertib | 7.4 | 0.64 |
| Tofacitinib | 7.1 | 0.68 |
| Defactinib | 6.8 | 0.45 |
| Alectinib | 6.5 | 0.65 |
| Bosutinib | 6.4 | 0.55 |
| Asciminib | 6.3 | 0.60 |
| Abrocitinib | 5.8 | 0.58 |
Known variants
No variants catalogued.